Hancock Whitney’s Herbalife HLF Stock Holding History

Hancock Whitney’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,647	Closed	-$584K	–	848
2019 Q2	$584K	Sell	13,647 -24,179	-64%	-$1.14M	0.02%	585
2019 Q1	$2M	Buy	37,826 +8,498	+29%	+$488K	0.06%	302
2018 Q4	$1.73M	Sell	29,328 -5,285	-15%	-$292K	0.06%	327
2018 Q3	$1.89M	Buy	+34,613	New	+$1.91M	0.05%	346

Other funds holding HLF

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Hancock Whitney's HLF Position: Q3 2019 in Review

Hancock Whitney sold out of Herbalife (HLF) in Q3 2019, closing a stake of 13,647 shares — an estimated $584K sold.

Hancock Whitney first reported a position in HLF in Q3 2018 and held it in 4 quarters. The position peaked at $2M in Q1 2019. 196 funds tracked by Wall St. Rank hold HLF as of Q3 2019.

Hancock Whitney reported no remaining Herbalife position as of Q3 2019 after selling out during the quarter.
Hancock Whitney sold 13,647 Herbalife shares in Q3 2019, an estimated $584K.
Hancock Whitney first reported a position in Herbalife in Q3 2018 and held it in 4 quarters.
Hancock Whitney's Herbalife position peaked at $2M in Q1 2019.
196 funds tracked by Wall St. Rank held Herbalife as of Q3 2019.

Based on Hancock Whitney's 13F filing for Q3 2019, filed 29 Oct 2019.